Clinical trials need to be more frank

by Medindia Content Team on  July 17, 2002 at 12:57 PM General Health News
RSS Email Print This Page Comment
Font : A-A+

Clinical trials need to be more frank
Doctors should keep their patients informed about being paid to enrol them in a clinical trial. Post-marketing surveillance or phase 4 clinical trials - are a signicnificant part of medical research. It involves giving patients a new drug and the family doctor reporting any problems that might arise. The post-marketing phase will involve many more patients than those who can take part in previous trials and can be an important way of revealing uncommon side effects.

Doctors will often be paid for their trouble in enrolling patients and keeping records. Researchers in the US felt that it's not always clear to the patient that the doctor is getting a cash benefit from their participation and this is wrong. It goes against the idea of informed consent - because the patient doesn't have all the facts - and it could lead to conflict of interests.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Placebo Effects: Rare Insights 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive